Trial intelligence / Profile preview

Deferoxamine for iron overload in hemodialysis patients

RBR-3rnskcjCompleted

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of deferoxamine in iron overload, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Change in ferritin, Change in serum iron and 1 more. Started Feb 2017; status: completed.

02

Drugs

deferoxamine
03

Conditions

iron overload

Beyond the preview

Go deeper on RBR-3rnskcj.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3rnskcj.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call